This inventor holds 2 USPTO granted patents. Top assignee: U3 Pharma Gmbh. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Innovations of Johannes Bange
Introduction
Johannes Bange is a notable inventor based in Planegg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of FGFR4 antibodies. With a total of two patents to his name, Bange's work is recognized for its potential impact on medical treatments.
Latest Patents
Johannes Bange's latest patents focus on FGFR4 antibodies. The present invention relates to FGFR4 antibodies, including fragments or derivatives thereof, and the polynucleotides encoding these antibodies. The patents also provide expression vectors and host cells comprising the polynucleotides. Furthermore, the invention refers to pharmaceutical compositions that include the FGFR4 antibodies and methods for the treatment, prevention, or diagnosis of disorders associated with FGFR4 expression.
Career Highlights
Bange is currently associated with U3 Pharma GmbH, where he continues to advance his research and innovations. His work in the company has been pivotal in the development of therapeutic solutions that address critical health issues.
Collaborations
Some of his notable coworkers include Jens Niewoehner and Patricia Aus Dem Siepen. Their collaborative efforts contribute to the innovative environment at U3 Pharma GmbH.
Conclusion
Johannes Bange's contributions to the field of biotechnology through his patents on FGFR4 antibodies highlight his role as an influential inventor. His work has the potential to lead to significant advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile